Dr. Shefali Dujari, MD

Dr. Dujari practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Dujari's NPI, 1801242953, was assigned on May 9, 2016. Dr. Dujari graduated from Boston University School of Medicine in 2016. Dr. Dujari holds California license A153524.

Dr. Dujari's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Dujari's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Dujari is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Dujari to 1 more hospital and 1 medical group, each named with a free account. Dr. Dujari's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dujari practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Dujari's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Dujari is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Dujari is licensed in California.

Dmand AI lists muscle pain, fibromyalgia, and limb pain and seizures among the conditions Dr. Dujari treats.

CMS data shows 357 Medicare services from Dr. Dujari across 5 procedure codes in 2024, for 212 Medicare patients. Medicare paid $40,953 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 212 Medicare patients who saw Dr. Dujari in 2024. The largest group is 65 to 74, with 75 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 37% are also on Medicaid. Their average risk score is 2.49, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dujari's median patient age at 56, with 53% women.

In 2024, Dr. Dujari wrote 27 Medicare Part D claims. 96% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $93 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Dujari for performance year 2024, reported as part of a group. Dr. Dujari accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Dr. Dujari, published from 2020 to 2024. 2020 was the busiest year, with 3. Dr. Dujari has published most often in Neurohospitalist. Dr. Dujari's most frequent co-authors are Carl Aaron Gold, MD, Kathryn Andrea Kvam, MD and Brian Jeffery Scott, MD.

Dr. Dujari graduated from Boston University School of Medicine in 2016.

Dr. Dujari is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.